These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15187391)

  • 1. A new method for disintegration studies of rapid disintegrating tablet.
    Narazaki R; Harada T; Takami N; Kato Y; Ohwaki T
    Chem Pharm Bull (Tokyo); 2004 Jun; 52(6):704-7. PubMed ID: 15187391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel and simple method to evaluate disintegration of rapidly disintegrating tablets.
    Hoashi Y; Tozuka Y; Takeuchi H
    Chem Pharm Bull (Tokyo); 2013; 61(9):962-6. PubMed ID: 23995360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.
    Harada T; Narazaki R; Nagira S; Ohwaki T; Aoki S; Iwamoto K
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1072-5. PubMed ID: 16880646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus.
    Desai PM; Liew CV; Heng PW
    Int J Pharm; 2013 Feb; 442(1-2):65-73. PubMed ID: 22985772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
    Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
    Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
    Hooper P; Lasher J; Alexander KS; Baki G
    J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterising the disintegration properties of tablets in opaque media using texture analysis.
    Scheuerle RL; Gerrard SE; Kendall RA; Tuleu C; Slater NK; Mahbubani KT
    Int J Pharm; 2015; 486(1-2):136-43. PubMed ID: 25791759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.
    Morita Y; Tsushima Y; Yasui M; Termoz R; Ajioka J; Takayama K
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1181-6. PubMed ID: 12237533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a new disintegration method for orally disintegrating tablets.
    Kakutani R; Muro H; Makino T
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):885-90. PubMed ID: 20606331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method.
    Que L; Wu W; Cheng X; Hu T
    Pharm Dev Technol; 2006; 11(3):295-301. PubMed ID: 16895840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
    Gupta A; Hunt RL; Shah RB; Sayeed VA; Khan MA
    AAPS PharmSciTech; 2009; 10(2):495-9. PubMed ID: 19387843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the disintegration mechanism and disintegration profiling of rapidly disintegrating tablets (RDTs) by thermal imaging.
    Ruhil S; Dahiya M; Kaur H; Singh J
    Int J Pharm; 2022 Jan; 611():121283. PubMed ID: 34775042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.
    Khan S; Kataria P; Nakhat P; Yeole P
    AAPS PharmSciTech; 2007 Jun; 8(2):Article 46. PubMed ID: 17622121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of dissolution and disintegration results for an immediate-release tablet.
    Nickerson B; Kong A; Gerst P; Kao S
    J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
    Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
    Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers.
    Yoshita T; Uchida S; Namiki N
    Biol Pharm Bull; 2013; 36(9):1488-93. PubMed ID: 23995661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for predicting disintegration time in the mouth of rapidly disintegrating tablet by compaction analysis using TabAll.
    Shibata Y; Yamamoto Y; Fujii M; Kondoh M; Watanabe Y
    Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1394-5. PubMed ID: 15516774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets.
    Koner JS; Rajabi-Siahboomi AR; Missaghi S; Kirby D; Perrie Y; Ahmed J; Mohammed AR
    Sci Rep; 2019 Aug; 9(1):12467. PubMed ID: 31462654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.